OBJECTIVE: To assess geospatial patterns of HIV antiretroviral therapy (ART) treatment facility use and whether they were impacted by viral load suppression. METHODS: We extracted data on the location and type of care services utilized by HIV-positive persons accessing ART between February 2015 and September 2016 from the Rakai Community Cohort Study in Uganda. The distance from Rakai Community Cohort Study households to facilities offering ART was calculated using the open street map road network. Modified Poisson regression was used to identify predictors of distance traveled and, for those traveling beyond their nearest facility, the probability of accessing services from a tertiary care facility. RESULTS: In total, 1554 HIV-positive participants were identified, of whom 68% had initiated ART. The median distance from households to the nearest ART facility was 3.10 km (interquartile range, 1.65-5.05), but the median distance traveled was 5.26 km (interquartile range, 3.00-10.03, P < 0.001) and 57% of individuals travelled further than their nearest facility for ART. Those with higher education and wealth were more likely to travel further. In total, 93% of persons on ART were virally suppressed, and there was no difference in the distance traveled to an ART facility between those with suppressed and unsuppressed viral loads (5.26 vs. 5.27 km, P = 0.650). CONCLUSION: Distance traveled to HIV clinics was increased with higher socioeconomic status, suggesting that wealthier individuals exercise greater choice. However, distance traveled did not vary by those who were or were not virally suppressed.
OBJECTIVE: To assess geospatial patterns of HIV antiretroviral therapy (ART) treatment facility use and whether they were impacted by viral load suppression. METHODS: We extracted data on the location and type of care services utilized by HIV-positive persons accessing ART between February 2015 and September 2016 from the Rakai Community Cohort Study in Uganda. The distance from Rakai Community Cohort Study households to facilities offering ART was calculated using the open street map road network. Modified Poisson regression was used to identify predictors of distance traveled and, for those traveling beyond their nearest facility, the probability of accessing services from a tertiary care facility. RESULTS: In total, 1554 HIV-positive participants were identified, of whom 68% had initiated ART. The median distance from households to the nearest ART facility was 3.10 km (interquartile range, 1.65-5.05), but the median distance traveled was 5.26 km (interquartile range, 3.00-10.03, P < 0.001) and 57% of individuals travelled further than their nearest facility for ART. Those with higher education and wealth were more likely to travel further. In total, 93% of persons on ART were virally suppressed, and there was no difference in the distance traveled to an ART facility between those with suppressed and unsuppressed viral loads (5.26 vs. 5.27 km, P = 0.650). CONCLUSION: Distance traveled to HIV clinics was increased with higher socioeconomic status, suggesting that wealthier individuals exercise greater choice. However, distance traveled did not vary by those who were or were not virally suppressed.
Authors: Babafemi O Taiwo; John A Idoko; Leah J Welty; Ihedinachi Otoh; Grace Job; Paul G Iyaji; Oche Agbaji; Patricia A Agaba; Robert L Murphy Journal: J Acquir Immune Defic Syndr Date: 2010-05-01 Impact factor: 3.731
Authors: Habib O Ramadhani; Nathan M Thielman; Keren Z Landman; Evaline M Ndosi; Feng Gao; Jennifer L Kirchherr; Rekha Shah; Humphrey J Shao; Susan C Morpeth; Jonathan D McNeill; John F Shao; John A Bartlett; John A Crump Journal: Clin Infect Dis Date: 2007-10-22 Impact factor: 9.079
Authors: James G Carlucci; Aniset Kamanga; Robb Sheneberger; Bryan E Shepherd; Cathy A Jenkins; John Spurrier; Sten H Vermund Journal: J Acquir Immune Defic Syndr Date: 2008-04-15 Impact factor: 3.731
Authors: Janneke H van Dijk; Catherine G Sutcliffe; Bornface Munsanje; Pamela Sinywimaanzi; Francis Hamangaba; Philip E Thuma; William J Moss Journal: PLoS One Date: 2011-04-28 Impact factor: 3.240
Authors: Mary K Grabowski; Justin Lessler; Andrew D Redd; Joseph Kagaayi; Oliver Laeyendecker; Anthony Ndyanabo; Martha I Nelson; Derek A T Cummings; John Baptiste Bwanika; Amy C Mueller; Steven J Reynolds; Supriya Munshaw; Stuart C Ray; Tom Lutalo; Jordyn Manucci; Aaron A R Tobian; Larry W Chang; Chris Beyrer; Jacky M Jennings; Fred Nalugoda; David Serwadda; Maria J Wawer; Thomas C Quinn; Ronald H Gray Journal: PLoS Med Date: 2014-03-04 Impact factor: 11.069
Authors: Jeffrey W Eaton; Laura Dwyer-Lindgren; Steve Gutreuter; Megan O'Driscoll; Oliver Stevens; Sumali Bajaj; Rob Ashton; Alexandra Hill; Emma Russell; Rachel Esra; Nicolas Dolan; Yusuf O Anifowoshe; Mark Woodbridge; Ian Fellows; Robert Glaubius; Emily Haeuser; Taylor Okonek; John Stover; Matthew L Thomas; Jon Wakefield; Timothy M Wolock; Jonathan Berry; Tomasz Sabala; Nathan Heard; Stephen Delgado; Andreas Jahn; Thokozani Kalua; Tiwonge Chimpandule; Andrew Auld; Evelyn Kim; Danielle Payne; Leigh F Johnson; Richard G FitzJohn; Ian Wanyeki; Mary I Mahy; Ray W Shiraishi Journal: J Int AIDS Soc Date: 2021-09 Impact factor: 6.707
Authors: Paul Mee; Brian Rice; Chodziwadziwa Whiteson Kabudula; Stephen M Tollman; Francesc Xavier Gómez-Olivé; Georges Reniers Journal: J Glob Health Date: 2020-12 Impact factor: 4.413
Authors: Andreas D Haas; Elizabeth Radin; Avi J Hakim; Andreas Jahn; Neena M Philip; Sasi Jonnalagadda; Suzue Saito; Andrea Low; Hetal Patel; Amee M Schwitters; John H Rogers; Koen Frederix; Evelyn Kim; George Bello; Daniel B Williams; Bharat Parekh; Karampreet Sachathep; Danielle T Barradas; Thokozani Kalua; Sehin Birhanu; Godfrey Musuka; Owen Mugurungi; Beth A Tippett Barr; Katrina Sleeman; Lloyd B Mulenga; Kyaw Thin; Trong T Ao; Kristin Brown; Andrew C Voetsch; Jessica E Justman Journal: J Int AIDS Soc Date: 2020-11 Impact factor: 5.396
Authors: M Kate Grabowski; Eshan U Patel; Gertrude Nakigozi; Victor Ssempijja; Robert Ssekubugu; Joseph Ssekasanvu; Anthony Ndyanabo; Godfrey Kigozi; Fred Nalugoda; Ronald H Gray; Sarah Kalibbala; David M Serwadda; Oliver Laeyendecker; Maria J Wawer; Larry W Chang; Thomas C Quinn; Joseph Kagaayi; Aaron A R Tobian; Steven J Reynolds Journal: J Infect Dis Date: 2021-04-08 Impact factor: 7.759
Authors: Maria F Nardell; Oluwatomi Adeoti; Carson Peters; Bernard Kakuhikire; Caroline Govathson-Mandimika; Lawrence Long; Sophie Pascoe; Alexander C Tsai; Ingrid T Katz Journal: J Int AIDS Soc Date: 2022-03 Impact factor: 5.396